Atrioverter: An implantable device for the treatment of atrial fibrillation

Circulation

Volumn 98, Issue 16, 1998, Pages 1651-1656

  Wellens, Hein J J ^a   Lau, Chu Pak ^b   Lüderitz, Berndt ^c   Akhtar, Masood ^d   Waldo, Albert L ^e   Camm, A John ^f   Timmermans, Carl ^a   Tse, Hung Fat ^b   Jung, Werner ^c   Jordaens, Luc ^g   Ayers, Gregory ^h  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c UNIVERSITY OF BONN   (Germany)

^d ST LUKE S MEDICAL CENTER   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^f ST GEORGE S HOSPITAL   (United Kingdom)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h In Control Inc   (United States)

Author keywords

Atrial defibrillation; Atrial fibrillation; Atrium

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; DEVICE; FEMALE; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HIS BUNDLE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SINUS RHYTHM;

EID: 7844219853     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.16.1651     Document Type: Article

References (30)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of atrial fibrillation: the Framingham study. N Engl J Med. 1982; 306:1018-1022.
2. Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge. JAMA. 1962;182:548-555.
3. Levy S, Lauribe P, Dolla E, Brémondy M, Calkins H, Das S, Morady F. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation. 1992;86:1415-1420.
4. Scheinman M, Morady F, Hess D, Gonzalez R. Catheter induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA. 1982;248:851-855.
5. Gallagher J, Svenson R, Kassel J, German LD, Bardy GH, Broughton A, Critelli G. Catheter technique for closed-chest ablation of the atrioventricular conduction system: a therapeutic alternative for the treatment of refractory supraventricular tachycardia. N Engl J Med. 1982;306: 194-200.
6. Williamson BD, Man KC, Daoud E, Niebauer M, Strickberger SA, Morady F. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med. 1994;331:910-917.
7. Moc GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther. 1962;140:183-188.
8. Allessie MA, Rensma PL, Brugada J, Smeets JRLM. Penn O, Kirchhof CJHJ. Pathophysiology of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1990:548-558.
9. Cox J, Boineau J, Schuessler R. A review of surgery of atrial fibrillation. J Cardiovasc Electrophysiol. 1991;2:541-561.
10. Haissaguerre M. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7: 1132-1144.
11. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
12. Jain SC, Bhatnagar WM, Azaml RU, Awasthey P. Elective countershock in atrial fibrillation with an intracardiac electrode: a preliminary report. J Assoc Physicians India. 1970;18:821-826.
13. Powell AC, Garan H, McGovern BA, Fallon JT, Krishnan SC, Ruskin JN. Low energy conversion of atrial fibrillation in the sheep. J Am Coll Cardiol. 1992;20:707-711.
14. Cooper RAS, Alferness CA, Smith WM, Ideker R. Internal cardioversion of atrial fibrillation in sheep. Circulation. 1993;87:1673-1686.
15. Ayers GM, Alferness CA, Ilina M, Smith WM, Cooper RAS, Ideker R. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation. 1994;89:413-422.
16. Sokoloski MC, Ayers GM, Kumagai K, Khrestian CM, Niwano S, Waldo AL. Safety of transvenous atrial defibrillation: studies in the canine sterile pericarditis model. Circulation. 1997;96:1343-1350.
17. Keelan ET, Krum D, Hare J, Mughal K, Li H, Akhtar M, Jazayeri MR. Safety of atrial defibrillation shocks synchronized to narrow and wide QRS complexes during atrial pacing protocols simulating atrial fibrillation in dogs. Circulation. 1997;96:2022-2030.
18. Alt E, Schmitt C, Ammer R, Coenen M, Fotuhi P, Karch M, Blasini R. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE Pacing Clin Electrophysiol. 1994;17: 1067-1078.
19. Saksena S, Prakash A, Mangeon L, Varanasi S, Kolettis T, Mathew P, De Groot P, Mehra R, Krol RB. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol. 1995;76:913-921.
20. Murgatroyd F, Slade AKB, Sopher M, Rowland E, Ward DE, Camm AJ. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol. 1995;25: 1347-1353.
21. Sra JS, Maglio C, Dhala A, Jazayeri MR, Akhtar M. Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation. J Am Coll Cardiol. 1996;28:1532-1538.
22. Schmitt C, Alt E, Plewan A, Ammer R, Leibig M, Karch M, Schömig A. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol. 1996;28:994-999.
23. Levy S, Ricard P, Lau CP, Lok NS. Camm AJ, Murgutroyd FO, Jordaens LJ, Kappenberger LJ, Brugada P, Ripley KL. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol. 1997;29:750-755.
24. Timmermans C. Rodriguez LM, Smeets JLRM, Wellens HJJ. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol. 1998;9:122-128.
25. Ammer R, Alt E, Ayers G, Schmitt C, Pasquantonio J, Schmitdt M, Pütter K, Schömig A. Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. Pacing Clin Electrophysiol. 1997;20:230-236.
26. Lok NS, Lau CP, Tse HF, Ayers GM. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol. 1997;30:1324-1330.
27. Jung J, Heisel A, Fries R, Köllner V. Tolerability of internal low-energy shock strengths currently needed for endocardial atrial cardioversion. Am J Cardiol. 1997;80:1489-1490.
28. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from directcurrent electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991;68:41-46.
29. Van Gelder IC, Crijns HJ, Tieleman RG, van Gilst WH, Lie KI. Chronic atrial fibrillation: success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 1996;156:2585-2593.
30. Marchlinski FE, Flores BT, Buxton AH, Miller J, Josephson ME. The automatic implantable cardioverter-defibrillator: efficacy, complications and device failures. Ann Intern Med. 1986;104:481-490.